Wells Fargo lowered the firm’s price target on Westlake (WLK) to $95 from $110 and keeps an Overweight rating on the shares. The firm is lowering its estimates for Westlake but remains bullish given its ability to generate nearly MSD quarter-over-quarter volume growth in HIP despite an unfavorable macro backdrop, and on potential near-term pricing tailwinds within PEM.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WLK:
- Resilient Growth and Strategic Positioning: Westlake Chemical’s Buy Rating Amidst Macroeconomic Challenges
- Westlake price target lowered to $117 from $132 at Truist
- Westlake price target lowered to $100 from $135 at Barclays
- Westlake Corporation Faces Challenges in Q1 2025
- Westlake Chemical’s Earnings Call: Mixed Results Amid Challenges